Merck Gets Bellwether Suit Slashed In Fosamax MDL
A New York federal judge on Tuesday dismissed every claim but one in a bellwether case in multidistrict litigation alleging Merck & Co. Inc.'s osteoperosis drug Fosamax causes jaw deterioration, allowing...To view the full article, register now.
Already a subscriber? Click here to view full article